28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Oxytocin sets the stage for childbirth by initiating uterine contractions, lactation and maternal bonding behaviours. Mice lacking secreted oxcytocin ( Oxt −/−, Cd38 −/−) or its receptor ( Oxtr −/−) fail to nurture. Normal maternal behaviour is restored by peripheral oxcytocin replacement in Oxt −/− and Cd38 −/−, but not Oxtr −/− mice, implying that circulating oxcytocin crosses the blood-brain barrier. Exogenous oxcytocin also has behavioural effects in humans. However, circulating polypeptides are typically excluded from the brain. We show that oxcytocin is transported into the brain by receptor for advanced glycation end-products (RAGE) on brain capillary endothelial cells. The increases in oxcytocin in the brain which follow exogenous administration are lost in Ager −/− male mice lacking RAGE, and behaviours characteristic to abnormalities in oxcytocin signalling are recapitulated in Ager −/− mice, including deficits in maternal bonding and hyperactivity. Our findings show that RAGE-mediated transport is critical to the behavioural actions of oxcytocin associated with parenting and social bonding.

          Abstract

          Yasuhiko Yamamoto et al. show that oxytocin is transported into the brain by the receptor for advanced glycation end-products (RAGE) on the blood-brain barrier. This study explains how circulating oxytocin crosses the blood-brain barrier, which is important to manifest oxytocin’s maternal bonding effects.

          Related collections

          Most cited references81

          • Record: found
          • Abstract: found
          • Article: not found

          Structure and function of the blood-brain barrier.

          Neural signalling within the central nervous system (CNS) requires a highly controlled microenvironment. Cells at three key interfaces form barriers between the blood and the CNS: the blood-brain barrier (BBB), blood-CSF barrier and the arachnoid barrier. The BBB at the level of brain microvessel endothelium is the major site of blood-CNS exchange. The structure and function of the BBB is summarised, the physical barrier formed by the endothelial tight junctions, and the transport barrier resulting from membrane transporters and vesicular mechanisms. The roles of associated cells are outlined, especially the endfeet of astrocytic glial cells, and pericytes and microglia. The embryonic development of the BBB, and changes in pathology are described. The BBB is subject to short and long-term regulation, which may be disturbed in pathology. Any programme for drug discovery or delivery, to target or avoid the CNS, needs to consider the special features of the BBB.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.

            Amyloid-beta peptide (Abeta) interacts with the vasculature to influence Abeta levels in the brain and cerebral blood flow, providing a means of amplifying the Abeta-induced cellular stress underlying neuronal dysfunction and dementia. Systemic Abeta infusion and studies in genetically manipulated mice show that Abeta interaction with receptor for advanced glycation end products (RAGE)-bearing cells in the vessel wall results in transport of Abeta across the blood-brain barrier (BBB) and expression of proinflammatory cytokines and endothelin-1 (ET-1), the latter mediating Abeta-induced vasoconstriction. Inhibition of RAGE-ligand interaction suppresses accumulation of Abeta in brain parenchyma in a mouse transgenic model. These findings suggest that vascular RAGE is a target for inhibiting pathogenic consequences of Abeta-vascular interactions, including development of cerebral amyloidosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Drug transport across the blood-brain barrier.

              The blood-brain barrier (BBB) prevents the brain uptake of most pharmaceuticals. This property arises from the epithelial-like tight junctions within the brain capillary endothelium. The BBB is anatomically and functionally distinct from the blood-cerebrospinal fluid barrier at the choroid plexus. Certain small molecule drugs may cross the BBB via lipid-mediated free diffusion, providing the drug has a molecular weight <400 Da and forms <8 hydrogen bonds. These chemical properties are lacking in the majority of small molecule drugs, and all large molecule drugs. Nevertheless, drugs can be reengineered for BBB transport, based on the knowledge of the endogenous transport systems within the BBB. Small molecule drugs can be synthesized that access carrier-mediated transport (CMT) systems within the BBB. Large molecule drugs can be reengineered with molecular Trojan horse delivery systems to access receptor-mediated transport (RMT) systems within the BBB. Peptide and antisense radiopharmaceuticals are made brain-penetrating with the combined use of RMT-based delivery systems and avidin-biotin technology. Knowledge on the endogenous CMT and RMT systems expressed at the BBB enable new solutions to the problem of BBB drug transport.
                Bookmark

                Author and article information

                Contributors
                yasuyama@med.kanazawa-u.ac.jp
                haruhiro@med.kanazawa-u.ac.jp
                Journal
                Commun Biol
                Commun Biol
                Communications Biology
                Nature Publishing Group UK (London )
                2399-3642
                25 February 2019
                25 February 2019
                2019
                : 2
                : 76
                Affiliations
                [1 ]ISNI 0000 0001 2308 3329, GRID grid.9707.9, Department of Biochemistry and Molecular Vascular Biology, , Kanazawa University Graduate School of Medical Sciences, ; Kanazawa, 920-8640 Japan
                [2 ]ISNI 0000 0001 2308 3329, GRID grid.9707.9, Department of Basic Research on Social Recognition and Memory, Research Centre for Child Mental Development, , Kanazawa University, ; Kanazawa, 920-8640 Japan
                [3 ]ISNI 0000 0001 0265 5359, GRID grid.411998.c, Medical Research Institute, , Kanazawa Medical University and Medical Care Proteomics Biotechnology Co., ; Uchinada, Ishikawa, 920-0293 Japan
                [4 ]ISNI 0000 0001 2308 3329, GRID grid.9707.9, Department of Neuroanatomy, , Kanazawa University Graduate School of Medical Sciences, ; Kanazawa, 920-8640 Japan
                [5 ]ISNI 0000 0001 2308 3329, GRID grid.9707.9, Department of Functional Anatomy, , Kanazawa University Graduate School of Medical Sciences, ; Kanazawa, 920-8640 Japan
                [6 ]ISNI 0000 0001 2308 3329, GRID grid.9707.9, Department of Neurosurgery, , Kanazawa University Graduate School of Medical Sciences, ; Kanazawa, 920-8640 Japan
                [7 ]ISNI 0000 0004 0550 5358, GRID grid.429269.2, Laboratory for Social Brain Studies, Research Institute of Molecular Medicine and Pathobiochemistry, and Department of Biochemistry, , Krasnoyarsk State Medical University, ; Krasnoyarsk, Russia 660022
                [8 ]ISNI 0000 0001 2308 3329, GRID grid.9707.9, Division of Transgenic Animal Science, , Kanazawa University Advanced Science Research Centre, ; Kanazawa, 920-8640 Japan
                [9 ]ISNI 0000 0001 2248 6943, GRID grid.69566.3a, Laboratory of Molecular Biology, Department of Molecular and Cell Biology, Graduate School of Agricultural Science, , Tohoku University, ; Sendai, 981-8555 Japan
                [10 ]ISNI 000000041936754X, GRID grid.38142.3c, Joslin Diabetes Centre & Harvard Medical School, ; Boston, MA 02215 USA
                [11 ]Komatsu University, Komatsu, 923-0921 Japan
                Article
                325
                10.1038/s42003-019-0325-6
                6389896
                30820471
                35973359-01ff-476d-82ed-943525017b1e
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 25 May 2018
                : 22 January 2019
                Categories
                Article
                Custom metadata
                © The Author(s) 2018

                Comments

                Comment on this article